Quarterly report pursuant to Section 13 or 15(d)

Schedule of Discontinuing Operations from Income Statement and Balance Sheet (Details)

v3.22.1
Schedule of Discontinuing Operations from Income Statement and Balance Sheet (Details) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2022
Dec. 31, 2021
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]    
Assets of discontinuing operations - current $ 1,001 $ 802
Assets of discontinuing operations - non-current 8,128 11,508
Liabilities of discontinued operations - current 3,760 3,522
Liabilities of discontinued operations - non-current 834 49
Vivo Pharm Disposal [Member]    
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]    
Revenue 1,353  
Cost of goods sold 775  
General and administrative 1,045  
Impairment of goodwill and intangible assets 4,290  
Total operating costs and expenses 6,110  
Loss from discontinuing operations (4,757)  
Total other income  
Loss from discontinuing operations before income taxes (4,757)  
Income tax benefit  
Net loss from discontinuing operations (4,757)  
Accounts receivable 542 457
Other current assets 459 345
Assets of discontinuing operations - current 1,001 802
Fixed assets, net of accumulated depreciation 191 163
Operating lease right-of-use assets 941 30
Intangible assets, net 6,634 8,787
Goodwill 2,164
Other assets 362 364
Assets of discontinuing operations - non-current 8,128 11,508
Accounts payable 442 358
Accrued expense 417 418
Obligation under operating lease, current 151 29
Obligation under finance lease, current 34 32
Deferred revenue 1,942 1,911
Taxes payable 365 365
Other current liabilities 409 409
Liabilities of discontinued operations - current 3,760 3,522
Obligations under operating leases, less current 794 2
Obligations under finance leases, less current 40 47
Liabilities of discontinued operations - non-current $ 834 $ 49